LoginSignup
LeMaitre logo

LeMaitre

Stock
Stock
Ticker: LMAT
LMAT

Price

Price

CHART BY

Historical dividends and forecast

All dividend data

LeMaitre has so far distributed $0.75 in 2026. The next dividend will be paid on 04.12.2026

$0.419

CHART BY

Frequently asked questions

The market capitalization of LeMaitre is $1.84B. Market capitalization is a measure of the total market value of a publicly traded company. It is calculated by multiplying the current stock price by the total number of outstanding shares.
The Price-to-Earnings (P/E) ratio (TTM) for LeMaitre is 28.67. This ratio helps investors assess whether a stock is overvalued or undervalued compared to its earnings.
LeMaitre's Earnings Per Share (EPS) over the trailing twelve months (TTM) is $2.807. EPS indicates the company's profitability on a per-share basis.
Currently, 8 analysts cover LeMaitre's stock, with a consensus target price of $107.00. Analyst ratings provide insights into the stock's expected performance.
Over the trailing twelve months, LeMaitre reported a revenue of $262.43M.
LeMaitre's Earnings before interest, taxes, depreciation, and amortization (EBITDA) over the trailing twelve months is $87.82M. EBITDA measures the company's overall financial performance.
LeMaitre has a free cash flow of $73.83M. Free cash flow indicates the cash generated after accounting for cash outflows to support operations and capital assets.
LeMaitre employs approximately 655 people. It operates in the Health Care sector, specifically within the Medical Specialties industry.
The free float of LeMaitre is 21.29M. Free float refers to the number of shares available for public trading, excluding restricted shares.

Financials

Market Cap 
$1.84B
EPS (TTM) 
$2.807
Free Float 
21.29M
P/E ratio (TTM) 
28.67
Revenue (TTM) 
$262.43M
EBITDA (TTM) 
$87.82M
Free Cashflow (TTM) 
$73.83M

Pricing

1D span
$79.25$80.83
52W span
$78.31$117.98

Analyst Ratings

The price target is $107.00 and the stock is covered by 8 analysts.

Buy

4

Hold

4

Sell

0

Information

LeMaitre Vascular, Inc. engages in the provision of medical devices and human tissue cryopreservation services. The company focuses on the design, marketing, sales, service, and technical support of medical devices and implants for the treatment of peripheral vascular disease. Its products include balloon catheters, carotid shunts, biologic patches, radiopaque marking tape, anastomotic clips, remote endarterectomy devices, laparoscopic cholecystectomy devices, vascular grafts, and powered phlebectomy. The company was founded by George D. LeMaitre on November 28, 1983 and is headquartered in Burlington, MA.

Employees
655
Industries
Medical Specialties
Sector
Health Care

Identifier

Primary Ticker
LMAT

Knockouts

Real-time data from LSX · Fundamentals & EOD data from FactSet
Join the conversation
Sign upLogin